Almudena Laris-Gonzalez

Dr. Almudena Laris-Gonzalez

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2020 in Vaccines
Verified
Journal Article
Open access
PDF file
ALAlmudena Laris-Gonzalez
Almudena Laris-Gonzalez
DBDaniel Bernal-Serrano
Daniel Bernal-Serrano
AJAlexander Jarde
Alexander Jarde
BKBeate Kampmann
Beate Kampmann
Live-attenuated vaccines (LAV) are currently contraindicated during pregnancy, given uncertain safety records for the mother–infant pair. LAV might, however, play an important role to protect them against serious emerging diseases, such as Ebola and Lassa fever. For this systematic review we searched relevant databases to identify studies published up to November 2019. Controlled observational studies reporting pregnancy outcomes after maternal immunization with LAV were included. The ROBINS-I tool was used to assess risk of bias. Pooled odds ratios (OR) were obtained under a random-effects model. Of 2831 studies identified, fifteen fulfilled inclusion criteria. Smallpox, rubella, poliovirus, yellow fever and dengue vaccines were assessed in these studies. No association was found between vaccination and miscarriage (OR 0.98, 95% CI 0.87–1.10), stillbirth (OR 1.04, 95% CI 0.74–1.48), malformations (OR 1.09, 95% CI 0.98–1.21), prematurity (OR 0.99, 95% CI 0.90–1.08) or neonatal death (OR 1.06, 95% CI 0.68–1.65) overall. However, increased odds of malformations (OR 1.24; 95% CI 1.03–1.49) and miscarriage after first trimester immunization (OR 4.82; 95% CI 2.38–9.77) was found for smallpox vaccine. Thus, we did not find evidence of harm related to LAV other than smallpox with regards to pregnancy outcomes, but quality of evidence was very low. Overall risks appear to be small and have to be balanced against potential benefits for the mother-infant pair.

5 March 2018 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
ALAlmudena Laris-Gonzalez
Almudena Laris-Gonzalez
MGMónica Villa Guillén
Mónica Villa Guillén
BMBriceida López Martínez
Briceida López Martínez
AGAna Gamiño-Arroyo
Ana Gamiño-Arroyo
SESarbelio Moreno Espinosa
Sarbelio Moreno Espinosa
DZDaniela De la Rosa Zamboni
Daniela De la Rosa Zamboni
Introduction: Healthcare personnel (HP) are frequently exposed to influenza and can be a source of transmission to patients and other workers, resulting in high‐cost outbreaks for healthcare institutions.Objectives: To analyse the presentation of HP with influenza‐like illness (ILI) and the differences between individuals with influenza confirmed by polymerase chain reaction (PCR) and those with a negative test. The secondary objective was to evaluate the duration of symptomatology and work absenteeism as well as the vaccination rate of HP at a paediatric referral hospital.Methods: A cross‐sectional, descriptive study was conducted at a paediatric referral hospital. Clinical and epidemiological data on HP with ILI were collected between January and April 2016. Nasopharyngeal swab for influenza PCR was obtained from one in every three workers with ILI. Telephone follow‐up was conducted to document duration of symptoms, complications and absenteeism.Results: A total of 164 ILI episodes were evaluated in 162 HP. A swab was obtained in 59 cases, and influenza was detected in 30 cases. The clinical picture of HP with confirmed influenza was similar to that of HP with a negative PCR. Arthralgia was more common in those with influenza (90% vs 58%), with a tendency towards statistical significance. No HP required hospitalization, and 78.5% were absent from work at least 1 day.Conclusions: Influenza causes significant morbidity and absenteeism among HP. Influenza infection was confirmed in only half of HP with an ILI on whom a PCR was performed, suggesting that other respiratory viruses can cause a similar pattern.

11 October 2025 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
OKOjeda-Diezbarroso Karla
Ojeda-Diezbarroso Karla
RJRodolfo Norberto Jiménez Juárez
Rodolfo Norberto Jiménez Juárez
AMAvilés-Robles Martha
Avilés-Robles Martha
ALAlmudena Laris-Gonzalez
Almudena Laris-Gonzalez
BSBonilla-Pellegrini Sergio
Bonilla-Pellegrini Sergio
CCCastellanos-Cruz Carmen
Castellanos-Cruz Carmen
Data on paediatric bloodstream infection (BSI) in low- and middle-income countries remain scarce. Consequently, this study aims to elucidate the risk factors associated with mortality in paediatric patients with enterobacterial BSIs. This was a retrospective analysis of patients with bloodstream infection due to Enterobacterales attended at Hospital Infantil de Mexico during 2013-2019. Factors influencing mortality were assessed. The baseline characteristics of the population, bloodstream infection and antimicrobial treatment were compared between survivors and non-survivors as well. Of 527 cases of BSIs, 63.6% (n = 335) were caused by Enterobacterales and 307 cases were included. The overall mortality rate was 11.1% (n = 34). In the multivariable regression model, septic shock/multiorgan failure (HR 9.69, 95% CI: 3.28-28.63), and empirical treatment failure (HR 3.4, 95% CI: 1.36-8.45) were associated with an increased mortality risk. in this study, the mortality in paediatric BSIs was driven by severe clinical presentation and failure to control inflammatory response and infection. Improving outcomes requires proactive measures, including early detection of sepsis by caregivers, education of healthcare providers for timely recognition and treatment, vigilant monitoring of systemic inflammatory response with adaptable therapeutic approaches and reinforcement of antimicrobial stewardship programs.

28 May 2025 in Viruses
Verified
Journal Article
Open access
PDF file
RJRodolfo Norberto Jiménez Juárez
Rodolfo Norberto Jiménez Juárez
SMSarbelio Moreno-Espinosa
Sarbelio Moreno-Espinosa
ALALFONSO REYES LOPEZ
ALFONSO REYES LOPEZ
IOISRAEL ORTEGA
ISRAEL ORTEGA
ALAlmudena Laris-Gonzalez
Almudena Laris-Gonzalez
AGAna Gamiño-Arroyo
Ana Gamiño-Arroyo
Influenza is a highly transmissible seasonal disease that significantly impacts public health worldwide, causing lower respiratory tract infections, numerous hospitalizations, and prolonged stays. However, data on its clinical burden in children in Latin America remain limited. This retrospective cohort study analyzed the demographic and clinical characteristics of children hospitalized with influenza in Latin America, stratified by age, and identified factors associated with mechanical ventilation. Medical records of children with severe acute respiratory infection associated with influenza were reviewed. Statistical analyses included chi square and Wilcoxon tests to compare groups, and Cox regression to identify predictors of mechanical ventilation. Among 212 cases, 46% of admissions were in school-age children; 93.4% had comorbidities. Influenza AH1N1 was more frequent in children 5 years of age. The mechanical ventilation rate per age group was 24.1% among those <1 year, 29.8% in 1–4 years of age, 4.9% in 5–9 years of age, and 26.3% in children 10–18 years of age. Hypotension, paradoxical breathing, and nosocomial infection were identified as predictors for mechanical ventilation. These findings enhance the understanding of influenza’s clinical impact on pediatric populations, particularly in predicting severe outcomes requiring intensive care, and aid in developing strategies to mitigate its effects.

25 September 2021
Verified
Preprint
Open access
PDF file
ALAlmudena Laris-Gonzalez
Almudena Laris-Gonzalez
MAMartha Aviles-Robles
Martha Aviles-Robles
SMSarbelio Moreno-Espinosa
Sarbelio Moreno-Espinosa
RJRodolfo Norberto Jiménez Juárez
Rodolfo Norberto Jiménez Juárez

30 January 2024
Verified
Preprint
Open access
PDF file
ALAlmudena Laris-Gonzalez
Almudena Laris-Gonzalez
MAMartha Aviles-Robles
Martha Aviles-Robles
CDClemen Domínguez-Barrera
Clemen Domínguez-Barrera
IPIsrael Parra-Ortega
Israel Parra-Ortega
JHJosé Luis Sánchez Huerta
José Luis Sánchez Huerta
RJRodolfo Norberto Jiménez Juárez
Rodolfo Norberto Jiménez Juárez
Introduction: Respiratory viruses are among the leading causes of disease and death among children. Co-circulation of influenza and SARS-CoV2 can lead to diagnostic and management difficulties given the similarities the clinical picture. Methods: This is a cohort of all children hospitalized with SARS-CoV2 infection from March to September 3rd 2020, and all children admitted with influenza throughout five flu-seasons (2013-2018) at a pediatric referral hospital. Patients with influenza were identified from the clinical laboratory database. All hospitalized patients with confirmed SARS-CoV2 infection were followed-up prospectively. Results: A total of 295 patients with influenza and 133 with SARS-CoV2 infection were included. The median age was 3.7 years for influenza and 5.3 years for SARS-CoV2. Comorbidities were frequent in both groups, but they were more common in patients with influenza (96.6% vs 82.7%, p <0.001). Fever and cough were the most common clinical manifestations in both groups. Rhinorrhea was present in more than half of children with influenza but was infrequent in those with COVID-19 (53.6 vs 5.8%, p<0.001). Overall, 6.4% percent of patients with influenza and 7.5% percent of patients with SARS-CoV2 infection died. In-hospital mortality and the need for mechanical ventilation among symptomatic patients were similar between groups in the multivariate analysis. Conclusions: Influenza and COVID-19 have a similar picture in pediatric patients, which makes diagnostic testing necessary for adequate diagnosis and management. Even though most cases of COVID-19 in children are asymptomatic or mild, the risk of death among hospitalized patients with comorbidities may be substantial, especially among infants.